Previous Article | Next Article ![]()
Infection and Immunity, March 2008, p. 888-898, Vol. 76, No. 3
0019-9567/08/$08.00+0 doi:10.1128/IAI.01301-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
,
Division of Infectious Diseases, Center for Childhood Infections and Prematurity Research,1 Center for Developmental Therapeutics, Seattle Children's Hospital Research Institute, Seattle, Washington,2 Departments of Pediatrics,3 Medical Education and Biomedical Informatics,4 Medicine, University of Washington School of Medicine, Seattle, Washington,5 The BIATECH Institute, Seattle, Washington,6 Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana7
Received 24 September 2007/ Returned for modification 25 October 2007/ Accepted 8 January 2008
|
|
|---|
|
|
|---|
While the interactions described above have been extensively characterized in vitro on a molecular level, the physical binding of any of the host proteins to their cognate bacterial receptor(s) in vivo during pneumonia has not been established. Virulence studies using rodent models of pneumonia have been performed to determine whether particular bacterial genes contribute to pneumonia. Strains containing mutations in the genes encoding sortase A, alpha-hemolysin, protein A, and the global virulence regulators SarA and AgrA exhibit attenuated virulence in mouse models of pneumonia (12, 18, 47). Sortase A catalyzes the anchoring of proteins, including protein A, into the cell wall peptidoglycan (30). Gomez et al. showed that protein A binds to TNFR1 to induce airway inflammatory responses during S. aureus infection (12). In addition, protein A expression increases in some Panton-Valentine leukocidin-expressing strains; increased levels of protein A may contribute to the overwhelming inflammatory response that occurs during necrotizing pneumonia caused by Panton-Valentine leukocidin-positive S. aureus (26). In contrast to the results of these studies, McElroy et al. demonstrated that a strain missing fibronectin binding proteins A and B was more virulent than the wild type in a rat model of intratracheal infection (33). The data from these virulence studies using isogenic S. aureus mutants defective in binding to host proteins clearly highlight the importance of determining the role of these molecular interactions in the pathogenesis of staphylococcal pneumonia.
To our knowledge, no data describing the specific interactions that occur between S. aureus and host proteins during early pneumonia are currently available. In addition, the roles of these specific interactions in allowing the bacterium to establish a niche in the airway and/or in providing the host with mechanisms promoting bacterial clearance are currently unknown. We provide evidence of a rapid and vigorous cytokine and neutrophil response to S. aureus in the airway during the first 6 h of infection by using our recently developed model of adult staphylococcal pneumonia (C. L. Ventura, R. Higdon, L. Hohmann, D. Martin, E. Kolker, H. D. Liggitt, S. J. Skerrett, and C. E. Rubens, submitted for publication). An analysis of the airway proteome in this model demonstrated a robust initial host response to infection. In this study, we used a shotgun proteomics approach to define the airway proteins that directly interact with S. aureus during the first 6 h after the bacterium enters the airway. We confidently identified 513 proteins that were associated with the bacterial cells during the initial stages of infection; in addition, we validated the use of shotgun proteomics to identify host proteins associated with bacteria during infection using immunoblotting techniques. The data presented here provide critical new information about the airway proteins associated with S. aureus upon the entry of the bacterium into the airway.
|
|
|---|
Incubation of S. aureus in human BAL fluid. BAL fluid was obtained from normal volunteers and frozen as described previously (38). The BAL fluid harvest protocol was approved by the Institutional Review Board of the University of Washington. S. aureus JP1 was grown overnight in TSB, harvested by centrifugation, and washed twice with PBS. Bacterial cells were resuspended in 1 ml of PBS or 1 ml of human BAL fluid and incubated for 2 h at 37°C. Triton X-100 was added to obtain a concentration of 0.1%, and the samples were incubated for 15 min at 37°C. Bacteria were pelleted by centrifugation and washed twice with PBS. Paired samples (one PBS sample and one BAL fluid sample) were incubated in Laemmli buffer (27) at 100°C for 10 min, Laemmli buffer at 37°C for 30 min, 0.5% sodium deoxycholate at 37°C for 30 min, 0.5% Triton X-100 at 37°C for 30 min, or 0.5% Tween 20 at 37°C for 30 min. Bacteria were pelleted by centrifugation for 5 min and discarded. Laemmli buffer containing bromophenol blue and glycerol was added to each supernatant prior to boiling for 5 min. Samples were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and stained with SYPRO Ruby (Bio-Rad, Hercules, CA). Proteins were detected using a gel documentation system (Bio-Rad).
Experimental design. Two independent biological experiments were performed to identify the host proteins that associate with S. aureus during early airway infection. In both experiments, 20 mice were inoculated intranasally with 3 x 108 CFU of S. aureus JP1. Ten mice were sacrificed at 30 min and at 6 h postinoculation, and BAL was performed. In the first experiment (see SCX in Table S1 in the supplemental material), BAL fluid was frozen immediately, thawed, and processed as described below in "Identification of mouse airway proteins associated with S. aureus." Recovered host proteins were digested with trypsin, separated by strong cation exchange (SCX) fractionation, and subjected to liquid chromatography-tandem mass spectrometry (LC-MS-MS) using an LCQ-DECA mass spectrometer. In the second experiment (see GEL in Table S1 in the supplemental material), BAL fluid was subjected to centrifugation at 300 x g for 10 min to remove eukaryotic cells. The BAL fluid was frozen and then thawed and processed as described below. Recovered host proteins were separated by one-dimensional (1D) SDS-PAGE and subjected to in-gel trypsin digestion, followed by LC-MS-MS using an LTQ mass spectrometer. Each biological sample was subjected to a single fractionation process and LC-MS-MS analysis.
Mouse model of pneumonia and BAL. Specific-pathogen-free male and female C57BL/6 mice, aged 8 to 12 weeks, were purchased from the Jackson Laboratory (Bar Harbor, ME). Animals were group housed in filtered, ventilated cages containing autoclaved bedding and were permitted ad libitum access to sterile food and water. Cage changes and animal handling occurred in a laminar flow hood. All experimental procedures were approved by the Institutional Animal Care and Use Committee of the University of Washington. For infection, mice were anesthetized with isoflurane, held vertically, and inoculated intranasally with 3 x 108 CFU of S. aureus JP1 in 50 µl of endotoxin-free PBS. At 30 min and at 6 h postinoculation in each of two experiments, 10 mice were euthanized and BAL was performed as described previously (41, 42). The BAL fluid samples were pooled by time point and processed as described above in "Experimental design."
Quantitation of cell-associated bacteria. Mice (10 per group) were inoculated intranasally as described above, and BAL fluid was harvested 30 min and 6 h postinoculation. An aliquot of BAL fluid from each animal was removed for quantitative culture and for the preparation of cytocentrifuge slides, which were stained by a modified Wright-Giemsa method using Diff-Quik (Dade-Behring, Dudingen, Switzerland) and scored for cell-associated bacteria, as described previously (41). Statistical analysis was performed using the Kruskal-Wallis test with Dunn's multiple-comparison posttest. A P value of <0.05 was considered significant.
Identification of mouse airway proteins associated with S. aureus. Upon thawing of the BAL samples, Triton X-100 was added to each sample to obtain a final concentration of 0.1% and the samples were vortexed for 10 s and incubated at 37°C for 15 min. The bacteria were pelleted by centrifugation at 10,000 x g for 15 min at 4°C and washed twice with 1 ml of PBS. Following centrifugation, the bacterial pellet was resuspended in 30 µl of Laemmli buffer (27) and the suspension was incubated for 30 min at 37°C. The cell debris was pelleted, and the supernatant containing the host proteins was stored at –80°C until further analysis. Each sample contained less than 20 µg of total protein; therefore, only one fractionation procedure and LC-MS-MS analysis could be performed on each biological sample, as described below.
For SCX fractionation and LC-MS-MS, samples were thawed and the proteins were precipitated twice with acetone. The protein pellet was resuspended in a mixture of 200 mM Tris (pH 8.3), 5 mM EDTA, 0.05% SDS, and 6 M urea, reduced in 2 mM Tris(2-carboxyethyl)phosphine for 30 min at 37°C, and alkylated in 2 mM iodoacetamide for 1 h in the dark at room temperature. The sample was diluted threefold and digested with 3 µg of trypsin for 3 h. Peptides were separated into three fractions by SCX using polysulfolethyl A (PolyLC, Inc., Columbia, MD) and a KCl buffer system (10-min gradient from 100% buffer A [25% acetonitrile {ACN}, 5 mM KH2PO4] to 35% buffer B [25% ACN, 5 mM KH2PO4, 360 mM KCl]). Fractions were desalted with a microspin C18 column (Nest Group) and subjected to LC-MS-MS using a Thermo-Finnigan LCQ-DECA ion trap mass spectrometer with an in-house microelectrospray ionization source. Each cation exchange fraction was loaded onto a 75-µm-internal-diameter fused-silica column packed with 10 cm of 5-µm-particle-size spherical C18 resin (Magic C18aq; Michrom Bioresources) and further separated using a 60-min linear gradient from 5 to 35% ACN in 0.1% formic acid at a 300-nl/min flow rate with an Agilent 1100 binary pump. Three MS-MS scans per MS scan were collected in a data-dependent manner.
For 1D gel electrophoresis and LC-MS-MS, BAL proteins were precipitated twice with acetone and separated in a Novex NuPAGE 4 to 12% bis-Tris gel (Invitrogen) at 200 V for 60 min. The proteins were silver stained according to established protocols (36), excised from the gel (in eight slices representing the entire lane of the gel for each sample), and washed extensively with water. Proteins were destained twice with a 1:1 solution of 100 mM sodium thiosulfate-30 mM potassium ferricyanide and washed twice with water. The gel slices were equilibrated in 25 mM ammonium bicarbonate (ambic) and dehydrated twice in 25 mM ambic-50% ACN. Proteins were reduced in a solution of 25 mM dithiothreitol in 25 mM ambic for 30 min at 56°C and alkylated in a solution of 550 mM iodoacetamide in 25 mM ambic for 30 min at room temperature in the dark. The gel slices were washed with water, reequilibrated in 25 mM ambic for 10 min, and dehydrated twice for 10 min in 25 mM ambic-50% ACN. The proteins were digested in the gel with trypsin (20 ng/ml) in 25 mM ambic for 16 to 24 h at 37°C. Following digestion, the peptides in the solution were extracted with 1 volume of 0.1% trifluoroacetic acid by vortexing for 20 min at room temperature, followed by two additional 20-min extraction steps with 1 volume of 5% trifluoroacetic acid-70% ACN. All extraction products were combined in one tube and dried. Following reconstitution, fractions were subjected to LC-MS-MS using a Thermo-Finnigan LTQ mass spectrometer fitted with an in-house-designed microspray device. Each fraction was loaded onto a 75-µm-internal-diameter fused-silica column packed with 10 cm of 5-µm-particle-size spherical C18 resin (Magic C18aq; Michrom Bioresources) and further separated using a 60-min linear gradient from 5 to 35% ACN in 0.1% formic acid at a 200-nl/min flow rate with an Agilent 1100 binary pump. Three MS-MS scans per MS scan were collected in a data-dependent manner.
Proteomics data analysis. The MS-MS scans from each LC-MS-MS run were converted from the .RAW file format into mzXML files using the program ReAdW.exe (Institute for Systems Biology, Seattle, WA). The database search program X!Tandem, included in the CPAS data analysis system, was used for peptide identification from the MS-MS spectra. The Comet scoring function was used in place of the default X!Tandem scoring function. The following parameters were used in the database search: trypsin enzyme specificity, a peptide mass tolerance of 2.5 Da, a fragment ion tolerance of 0.5 Da, monoisotopic molecular weights for both the peptide and the fragment ion masses, the b/y ion search, variable modification at M of +15.995, and static modification at C of +57.1. The data were compared against a combined database consisting of the mouse IPI version 3.22, S. aureus COL, and a list of contaminants. In addition, randomly reshuffled versions of each database were also appended.
A composite peptide identification score was generated from the X!Tandem output based on the combination of the Comet score, the degree of difference from the second best match, the expectation value, the percentage of matching ions, the charge state, the peptide length, and the difference between the observed and theoretical masses by using the logistic identification of peptide sequences model (19). Experiment-specific peptide identification probabilities were generated from the distribution of reshuffled peptide matches (20). A minimum 90% identification certainty was used to accept a peptide spectrum identification. This parameter resulted in an overall false-positive peptide identification rate of 0.5% (with a 95% upper bound of 0.7%) based on reshuffled database matches. Protein identification for each experimental condition was based on four levels of certainty (very high, high, medium, and low). All proteins identified by using two or more unique peptides were classified with a very high level of certainty. Single-hit proteins were classified in the remaining three certainty levels based on a model using the peptide identification probability and the peptide length (20). The estimated false-discovery rates for the four categories are 0, 1.4, 19, and 32% (with 95% upper bounds of 0.4, 2.5, 32, and 54%). Proteins identified with very high or high certainty were considered to be confidently identified and were described further.
Western immunoblotting. Groups of five mice were inoculated as described above with JP1 or PBS, and BAL fluid was harvested 30 min and 6 h following inoculation, pooled, and frozen at –80°C until use. BAL fluids from PBS-inoculated animals were used as controls for insoluble airway protein in the processing of the samples and were treated exactly the same as the infected samples. Upon thawing of the samples at room temperature, Triton X-100 was added to obtain a concentration of 0.1% and the BAL fluids were vortexed for 15 s. Bacteria were harvested by centrifugation at 4,000 x g for 10 to 20 min and then resuspended in 1 ml of the same BAL fluid and harvested again at 16,100 x g for 5 min. The bacteria were resuspended in 30 µl of Laemmli buffer (27) and incubated for 30 min at 37°C. Following centrifugation at 16,100 x g for 5 min, the supernatants containing the airway proteins were separated by SDS-PAGE using 4 to 20% Criterion gradient gels (Bio-Rad). Following SDS-PAGE, proteins were transferred onto nitrocellulose membranes by using a Trans-Blot SD semidry electrophoretic transfer apparatus (Bio-Rad). Membranes were blocked and antibodies were diluted using Odyssey blocking buffer (Li-Cor Biosciences, Lincoln, NE) mixed 1:1 with PBS. The primary antibody was rabbit anti-mouse hemoglobin (MP Biomedicals, Aurora, OH), the secondary antibody was goat anti-rabbit Ig conjugated to horseradish peroxidase (Bio-Rad), and the tertiary antibody was donkey anti-goat Ig conjugated to Alexa Fluor 680 (Invitrogen, Carlsbad, CA). Hemoglobin was detected using an Odyssey infrared imaging system (Li-Cor Biosciences).
|
|
|---|
![]() View larger version (26K): [in a new window] |
FIG. 1. Laemmli buffer effectively removes airway proteins from the surfaces of S. aureus cells with minimal bacterial protein contamination. S. aureus JP1 was incubated with PBS or human BAL fluid and treated to remove the BAL proteins from the bacterial surface, and the BAL proteins were separated by SDS-PAGE and stained with SYPRO Ruby. Lanes 1, 3, 5, 7, and 9, JP1 incubated in PBS; lanes 2, 4, 6, 8, and 10, JP1 incubated in BAL fluid. BAL proteins were removed under the following conditions: lanes 1 and 2, Laemmli buffer at 100°C; lanes 3 and 4, Laemmli buffer at 37°C; lanes 5 and 6, 0.5% sodium deoxycholate at 37°C; lanes 7 and 8, 0.5% Tween 20 at 37°C; lanes 9 and 10, 0.5% Triton X-100.
|
A total of 513 host proteins were confidently identified as being associated with S. aureus 30 min and/or 6 h following inoculation (see Table S1 in the supplemental material), with 288 (56%) of those proteins identified with very high confidence (using at least two peptides). Fractionation by 1D SDS-PAGE yielded 386 protein identifications, while SCX fractionation resulted in the identification of 219 proteins; 92 proteins (18% of the total) were identified following both fractionation approaches. A larger number of proteins was associated with S. aureus at 6 h after inoculation than at 30 min (358 versus 295 proteins, respectively); of these, 197 and 162 proteins, respectively, were identified with very high confidence. Interestingly, 155 proteins were identified at 30 min and not at 6 h, while 218 proteins were identified only at 6 h. Of those proteins identified with very high confidence at only one time point (65 at 30 min and 104 at 6 h), 27% were identified by using at least five unique peptides and 42% were identified by using at least four peptides. Taken together, these data strongly suggest that the complement of associated host proteins changed significantly during early infection.
Phagocytic proteins rapidly associated with S. aureus in the airway. A cellular component Gene Ontology (GO) category was assigned to each identified protein (Fig. 2A and B). A majority of the proteins (83 and 76% of the total proteins identified at 30 min and 6 h, respectively) were characterized as being intracellular, suggesting that (i) S. aureus was internalized rapidly in the airway, (ii) a significant amount of host cell lysis occurred during infection, possibly as a result of apoptosis, necrosis, and/or S. aureus toxin-mediated cytolysis, and/or (iii) host cell lysis and subsequent centrifugation of intracellular proteins onto the bacteria occurred during sample processing. To determine if S. aureus was associated with alveolar macrophages (AMs) and polymorphonuclear leukocytes (PMNs) during the first 6 h following inoculation, the number of cell-associated bacteria in BAL specimens was determined (it is important to note that this method does not distinguish intracellular from surface-bound bacteria). By 30 min postinoculation, bacteria were associated with 65% ± 6% (mean ± standard error of the mean) of AMs; the percentage of AMs associated with S. aureus did not change significantly during the first 6 h of infection (60% ± 6% at 6 h), indicating that association with and/or uptake by AMs was avid and very rapid. PMNs were nearly undetectable in the airway 30 min following inoculation, but the proportion of PMNs associated with S. aureus at 6 h was 25% ± 4%. Because S. aureus was associated with and/or internalized by AMs and PMNs in the airway, we determined if any of the host proteins identified as being associated with S. aureus were phagosomal proteins. Recent proteomics studies have defined the proteins present in phagosomes resulting from the internalization of latex beads by AMs and PMNs (3, 11). Of the 513 total proteins associated with S. aureus, 105 have been shown to be present in the phagosome (Table 1) . At least 70 phagosomal proteins were associated with S. aureus 30 min after inoculation, with 78 phagosomal proteins associated after 6 h. Cytoskeletal proteins, including actin and actin binding proteins (alpha-actinin and F-actin capping protein), would be predicted to interact with S. aureus during actin rearrangement events that occur early during phagocytosis. Proteolytic and inflammatory proteins, including cathepsins D and G, calgranulin A, catalase, cathelicidin antimicrobial peptide, and myeloperoxidase, are present in late phagosomes and lysosomes and play an important role in killing intracellular bacteria. Interestingly, S. aureus is relatively resistant to phagocytic killing and survives within the phagocytic cell (15).
![]() View larger version (30K): [in a new window] |
FIG. 2. A total of 513 airway proteins were associated with S. aureus in the first 6 h of infection (see Table S1 in the supplemental material for a complete list of proteins). The proteins identified at 30 min (A) and 6 h (B) were divided into GO cellular component categories. The extracellular proteins identified at 30 min (C) and 6 h (D) were further categorized according to the corresponding GO biological processes.
|
|
View this table: [in a new window] |
TABLE 1. Proteins previously identified in phagosomes associate with S. aureus in the airway 30 min and/or 6 h postinoculation
|
|
View this table: [in a new window] |
TABLE 2. Extracellular host proteins associate with S. aureus in the airway 30 min and/or 6 h postinoculation
|
|
View this table: [in a new window] |
TABLE 3. Airway proteins implicated in host-pathogen interactions associate with S. aureus during airway infection
|
![]() View larger version (18K): [in a new window] |
FIG. 3. Hemoglobin associates with S. aureus 30 min and 6 h postinoculation into the airway. Bacteria were recovered from the BAL fluids of mice inoculated with S. aureus, and host proteins were harvested as described in Materials and Methods. The host proteins were separated by SDS-PAGE, transferred onto nitrocellulose membranes, and probed with antibodies against mouse hemoglobin. Lanes: 1, BAL fluid containing hemoglobin (control); 2, sample from 30 min postinoculation; 3, sample from 6 h postinoculation. Numbers on the left indicate molecular sizes in kilodaltons.
|
|
|
|---|
We did not attempt to separate intracellular and extracellular bacteria but rather sampled the entire population in the airway to identify as many associated host proteins as possible. Therefore, the subcellular source of the proteins we detected included every compartment of the host cell, as well as the extracellular milieu. Nearly 80% of the proteins we identified were intracellular proteins, suggesting that S. aureus was rapidly internalized in the airway and that S. aureus infection caused rapid host cell lysis, presumably as a result of apoptosis, necrosis, or S. aureus toxin activity. S. aureus has previously been shown to be phagocytosed by AMs as rapidly as 30 min postinoculation in an aerosolization model (13, 23, 28); thus, it is not surprising that we detected a large number of phagosomal proteins associated with S. aureus 30 min and 6 h postinoculation. In fact, of the 404 intracellular proteins, 105 of them have previously been shown to be components of the phagosomal proteome of macrophages and/or PMNs (3, 11). It is important to point out that the association of these host proteins with the phagosome does not imply that they are found solely in the phagosome. In fact, nearly all of the proteins identified as being phagosomal play other roles in the cell that are unrelated to phagocytosis specifically. We identified proteins specific to different stages of phagosomal maturation at both time points. Actin, coronin, myosin, T-complex protein 1, and Rho GDP dissociation inhibitors are critical to the actin rearrangement process that occurs to facilitate the extension of pseudopodia, an early step in the phagocytic process (8, 45). The identification of proteins such as Rab7, Rab11B, and syntenin suggests that S. aureus is present in late endosomes; these three proteins are specific to late phagosomes that are preparing to fuse with lysosomes in the phagosome maturation process (8, 45). These data, combined with our data showing that S. aureus is rapidly associated with or internalized by AMs and PMNs in the airway, provide additional evidence to support the findings of previous studies demonstrating that the phagocytosis of S. aureus occurs quickly (13, 23, 28) and is followed by the survival of the bacteria within the phagocytes (15).
While we believe that the majority of the intracellular proteins that were identified were associated with S. aureus as a result of phagocytosis or host cell lysis in vivo, we acknowledge that the manner in which the samples were processed may have contributed to the identification of these proteins. BAL samples from infected mice were frozen, and Triton X-100 was added to thawed samples in order to solubilize aggregated host proteins in the BAL fluid. During the subsequent high-speed centrifugation to harvest the bacteria, intracellular host proteins that were present in the BAL fluid as a result of host cell lysis (in vivo as a result of infection or ex vivo during processing) may have become associated with S. aureus. The bacterial pellets were thoroughly washed twice with PBS following the initial harvest in an attempt to disrupt any nonspecific interactions between the bacteria and irrelevant host proteins. The following arguments support the conclusion that the host proteins identified as being associated with S. aureus in the airway represent biologically relevant interactions. (i) Two different separation and mass spectrometric approaches were utilized to define the host proteins, resulting in an overlap in protein identification of nearly 20% between unique biological samples. (ii) The complement of host proteins associated with S. aureus changed during the course of early infection; if sample processing had contributed significantly to protein identification, one would expect that the same proteins would have been identified in samples from both time points, when in fact 53 and 61% of the proteins identified 30 min and 6 h postinoculation, respectively, were unique to that time point. (iii) Twelve of 16 host proteins known to interact with S. aureus in vitro were identified in our in vivo analysis, and 8 of these 12 proteins were identified in biological samples from both time points. (iv) Immunoblot analysis allowed us to confirm the presence of hemoglobin on the surfaces of S. aureus cells recovered from the airway. Taken together, these arguments provide strong support for the conclusion that the majority of the host proteins that were associated with S. aureus during early infection represent potentially biologically relevant phenomena that should be characterized further.
Previous studies have identified at least 16 host proteins that bind to S. aureus via either a receptor ligand or a nonspecific interaction (Table 3). In this study, we demonstrated that at least 12 of these proteins were present on the surfaces of S. aureus cells 30 min and/or 6 h following the inoculation of the bacteria into the airway. Complement C3, Igs, and pulmonary surfactant protein A are capable of opsonizing S. aureus via both nonspecific (complement C3 and pulmonary surfactant protein A) and specific (Igs) mechanisms. Interestingly the S. aureus receptors for complement C3 and Igs, Efb, and protein A, respectively, have antiopsonic properties. The extracellular fibrinogen binding protein Efb inhibits opsonophagocytosis by binding complement C3, thus preventing complement C3 from opsonizing the bacteria (29). Protein A is the most abundant protein on the surfaces of S. aureus cells and has been shown to be critical for the survival of S. aureus in the airway (12, 26, 47). Protein A binds the Fc portion of IgG molecules and renders the IgG molecules inaccessible to the Fc receptor on the surfaces of phagocytic cells, thus providing S. aureus with a mechanism for preventing antibody-mediated phagocytosis. In addition, previous studies in our laboratory have demonstrated that cathelicidin is capable of binding to staphylokinase to enhance the ability of staphylokinase to activate plasminogen and promote fibrinolysis, thus providing the organism with a mechanism for disseminating systemically (2). Thus, the pathogen has several mechanisms for evading host innate immune factors through direct binding to host proteins.
The four proteins previously shown to interact with S. aureus that we did not identify in our analysis are elastin, laminin, TNFR1, and von Willebrand factor (4, 12). Potential reasons for our inability to detect these proteins include the following: (i) the proteins were not present in the airway at the time points that we analyzed; (ii) the shotgun proteomics approach is not sufficiently sensitive to detect all of the proteins present in a complex mixture, particularly those present in low abundance; (iii) the proteins were present but did not bind to S. aureus in the airway; and (iv) the fractionation techniques (1D SDS-PAGE, SCX, and LC) may have eliminated proteins with extreme charges or molecular weights. The first explanation is supported by the results of our analysis of the airway proteome 30 min and 6 h postinoculation with JP1; we did not identify peptides corresponding to any of these four proteins in the airway at either time point (Ventura et al., submitted), which suggests that these proteins may not be present in the airway. Alternatively, our inability to detect these proteins in the airway may be a reflection of the fact that we sampled the proteins present in the lavage fluid rather than those present in the entire lung, which may preclude the identification of membrane or intracellular proteins. Further studies using later time points and/or different animal models are necessary to determine when the interactions between S. aureus and any of these four proteins are important for virulence.
Shotgun proteomics proved to be an extremely useful tool for identifying airway proteins that associate with S. aureus during the early stages of pneumonia. To our surprise, over 500 host proteins were found to interact with S. aureus 30 min and/or 6 h postinoculation. We were able to confirm the binding of one of these proteins, hemoglobin, to S. aureus at both time points by using an alternative method. The data presented here provide critical information regarding known as well as previously undescribed host-pathogen interactions that occur between S. aureus and the host during early airway infection. Further, these data form the foundation for future studies of the specific interactions between the host and the pathogen during the initial steps in the pathogenesis of pneumonia.
This work was supported by grant HL073996 from the National Institutes of Health (to C.E.R.).
Published ahead of print on 14 January 2008. ![]()
Supplemental material for this article may be found at http://iai.asm.org/. ![]()
|
|
|---|
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»